Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop.

Given the significance of the immune system and the important role of therapies within the context of the immune system in plasma cell disorders, the International Myeloma Society annual workshop convened a session dedicated to this topic. A panel of experts covered various aspects of immune reconstitution and vaccination. The top oral presentations were highlighted and discussed. This is a report of the proceedings.
Competing Interests: Disclosure E.T. has received honoraria from Amgen, Astra/Zeneca, Bristol Myers Squibb, Eusa Pharma, GSK, Integris Pharma, Janssen, Pfizer, Sanofi and Takeda; research grants from Amgen, GSK, Janssen, Sanofi and Takeda and travel grants from Amgen, Eusa Pharma and Takeda. P.N. has received speaker's bureau honoraria from BMS, Janssen, Sanofi and Pfizer and is a consultant/advisory board member for Janssen, Sanofi, and Pfizer. N.W.C.J.v.d.D. has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Novartis, Cellectis and BMS, and serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Takeda, Roche, Novartis, and Adaptive, all paid to institution. M.D. has received research support from Janssen Pharmaceuticals; has received honoraria for lectures from GlaxoSmithKline, Sanofi, and Janssen; has served on advisory boards for GlaxoSmithKline, Sanofi, and Bristol Myers Squibb. S.P. has served on advisory boards for Grail and Genentech; has received research support from Amgen Inc. and Celgene/BMS Corporation. H.L. has received honoraria for advisory boards or lectures from Celgene, Janssen-Cilag, Takeda, Amgen, BMS, Sanofi, Abbvie, Pfizer, Seattle Genetics; has received research support from Amgen, and Sanofi. D.E.A. has received research support from Celgene, Pharmacyclics, and Kite Pharma; has served as consultant for Parexel, Kite Pharma, Takeda, Sanofi, Kowa, and Janssen; has served on advisory boards for Celgene, Juno, Partners TX, Karyopharm, Bristol Myers Squibb, Aviv MedTech Ltd., Takeda, Legend Bio Tech, Chugai, Kite Pharma, and Caribou Biosciences. M.V.D. has served on advisory boards for Janssen, Sanofi, BMS, Lava Therapeutics. N.S.R. declares consultancy and advisory boards for Pfizer, BMS, Janssen, Sanofi, Abbvie, Regeneron, Amgen, Caribou, Immuneel; has received research funding from Pfizer and 2Seventybio.
(Copyright © 2023 Elsevier Inc. All rights reserved.)